Breast Carcinoma with Oncotype DX Recurrence Score Lower Than 18: Rate of Distant Metastases in a Large Series with Clinical Follow-Up

BACKGROUNDS: A 21-gene expression assay (Oncotype DX™ Recurrence Score (“RS”)) that utilizes RT-PCR is used clinically in early-stage estrogen receptor-positive, HER2-negative breast carcinoma (ER+/HER2− BC) to determine both prognosis with tamoxifen therapy and the utility of adding adjuvant chemot...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer
Hoofdauteurs: Wen, Hannah Y, Krystel-Whittemore, Melissa, Patil, Sujata, Pareja, Fresia, Bowser, Zenica L, Dickler, Maura N., Norton, Larry, Morrow, Monica, Hudis, Clifford A., Brogi, Edi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5161549/
https://ncbi.nlm.nih.gov/pubmed/27526056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30271
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items